Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 350

1.

Sociodemographic factors associated with nephrectomy in patients with metastatic renal cell carcinoma.

Hellenthal NJ, Chamie K, Ramirez ML, deVere White RW.

J Urol. 2009 Mar;181(3):1013-8; discussion 1018-9. doi: 10.1016/j.juro.2008.10.159. Epub 2009 Jan 16.

PMID:
19150554
2.

Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.

Vasselli JR, Yang JC, Linehan WM, White DE, Rosenberg SA, Walther MM.

J Urol. 2001 Jul;166(1):68-72.

PMID:
11435825
3.

Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.

Kassouf W, Sanchez-Ortiz R, Tamboli P, Tannir N, Jonasch E, Merchant MM, Matin S, Swanson DA, Wood CG.

J Urol. 2007 Nov;178(5):1896-900. Epub 2007 Sep 17.

PMID:
17868729
4.

Cytoreductive nephrectomy in the elderly patient: the M. D. Anderson Cancer Center experience.

Kader AK, Tamboli P, Luongo T, Matin SF, Bell K, Jonasch E, Swanson DA, Wood CG.

J Urol. 2007 Mar;177(3):855-60; discussion 860-1.

PMID:
17296358
5.

Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma.

Zini L, Capitanio U, Perrotte P, Jeldres C, Shariat SF, Arjane P, Widmer H, Montorsi F, Patard JJ, Karakiewicz PI.

Urology. 2009 Feb;73(2):342-6. doi: 10.1016/j.urology.2008.09.022. Epub 2008 Nov 28.

PMID:
19041122
6.

Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy.

Thompson RH, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED, Cheville JC, Blute ML.

J Urol. 2008 Feb;179(2):468-71; discussion 472-3.

PMID:
18076931
7.

Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study.

Capitanio U, Zini L, Perrotte P, Shariat SF, Jeldres C, Arjane P, Pharand D, Widmer H, Péloquin F, Montorsi F, Patard JJ, Karakiewicz PI.

Urology. 2008 Nov;72(5):1090-5. doi: 10.1016/j.urology.2008.06.059. Epub 2008 Sep 16.

PMID:
18799207
8.

The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma.

Krambeck AE, Leibovich BC, Lohse CM, Kwon ED, Zincke H, Blute ML.

J Urol. 2006 Nov;176(5):1990-5; discussion 1995.

PMID:
17070231
9.

Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.

Pantuck AJ, Zisman A, Dorey F, Chao DH, Han KR, Said J, Gitlitz BJ, Figlin RA, Belldegrun AS.

J Urol. 2003 Jun;169(6):2076-83.

PMID:
12771723
10.

Potential role of nephrectomy in the treatment of metastatic renal cell carcinoma: a retrospective analysis.

Tigrani VS, Reese DM, Small EJ, Presti JC Jr, Carroll PR.

Urology. 2000 Jan;55(1):36-40.

PMID:
10654891
11.

Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy.

Tatokoro M, Saito K, Iimura Y, Fujii Y, Kawakami S, Kihara K.

J Urol. 2008 Aug;180(2):515-9. doi: 10.1016/j.juro.2008.04.025. Epub 2008 Jun 11.

PMID:
18550105
12.

A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States.

Jeldres C, Baillargeon-Gagne S, Liberman D, Isbarn H, Capitanio U, Shariat SF, Sun M, Lughezzani G, Perrotte P, Montorsi F, Graefen M, Karakiewicz PI.

Urology. 2009 Oct;74(4):837-41. doi: 10.1016/j.urology.2009.04.019. Epub 2009 Jul 18.

PMID:
19616828
13.
14.

Is there a role for partial nephrectomy in patients with metastatic renal cell carcinoma?

Hellenthal NJ, Mansour AM, Hayn MH, Schwaab T.

Urol Oncol. 2013 Jan;31(1):36-41. doi: 10.1016/j.urolonc.2010.08.026. Epub 2011 Mar 10.

PMID:
21396834
15.

Outcome after cytoreductive nephrectomy for metastatic renal cell carcinoma is predicted by fractional percentage of tumour volume removed.

Pierorazio PM, McKiernan JM, McCann TR, Mohile S, Petrylak D, Benson MC.

BJU Int. 2007 Oct;100(4):755-9.

16.

Is there a place for radical nephrectomy in the presence of metastatic collecting duct (Bellini) carcinoma?

Méjean A, Rouprêt M, Larousserie F, Hopirtean V, Thiounn N, Dufour B.

J Urol. 2003 Apr;169(4):1287-90.

PMID:
12629344
17.

Stage IV renal cell carcinoma.

Frank W, Stuhldreher D, Saffrin R, Shott S, Guinan P.

J Urol. 1994 Dec;152(6 Pt 1):1998-9.

PMID:
7966660
18.

Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.

Klatte T, Patard JJ, de Martino M, Bensalah K, Verhoest G, de la Taille A, Abbou CC, Allhoff EP, Carrieri G, Riggs SB, Kabbinavar FF, Belldegrun AS, Pantuck AJ.

J Urol. 2008 May;179(5):1719-26. doi: 10.1016/j.juro.2008.01.018. Epub 2008 Mar 17.

PMID:
18343437
19.

Increased risk of overall and cardiovascular mortality after radical nephrectomy for renal cell carcinoma 2 cm or less.

Kates M, Badalato GM, Pitman M, McKiernan JM.

J Urol. 2011 Oct;186(4):1247-53. doi: 10.1016/j.juro.2011.05.054. Epub 2011 Aug 17.

PMID:
21849201
20.

Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy.

Boorjian SA, Crispen PL, Lohse CM, Leibovich BC, Blute ML.

J Urol. 2008 Jul;180(1):99-103; discussion 103. doi: 10.1016/j.juro.2008.03.025. Epub 2008 May 15.

PMID:
18485415
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk